Keywords: clinical, trial, news, brief, geltex, pharmaceuticals, begun
Clinical Trial News In Brief
Article | 20 January 1998
GelTex Pharmaceuticals has begun the first of two Phase III trials ofCholestaGel, its non-absorbed cholesterol-lowerer for the treatment of hypercholesterolemia. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
